Le Lézard
Classified in: Health
Subjects: AWD, TRI

The Prostate Cancer Foundation Announces Recipients Of The 2018 PCF Young Investigator Awards


LOS ANGELES, Aug. 28, 2018 /PRNewswire/ -- The Prostate Cancer Foundation (PCF) announced today that it has granted a total of $6 million to 29 promising early career scientists dedicated to advancing critical research in developing better early detection methods, improving life-saving treatments and finding a cure for prostate cancer. Sponsored by the PCF, the Young Investigator Awards program provides both financial support and a comprehensive career development program to early career scientists with unique approaches and groundbreaking ideas to drive the critical research needed to defeat prostate cancer, a disease that nearly 14 million men worldwide are currently battling.

"We are honored to invest in new cutting-edge ideas for prostate cancer research.  This year's recipients show great potential for unlocking new discoveries and achieving unprecedented strides toward research leading the way to help countless men affected by the disease," said Jonathan Simons, MD, PCF's President and CEO.

As a nonprofit organization committed to globally accelerating the development of new breakthroughs in prostate cancer, the PCF has invested more than $53 million to support 255 young investigators since 2007. The 2018 Young Investigator Awards recipients were selected from a pool of 103 applications from 55 institutions in 11 countries. 

Recipients of the PCF Young Investigator Award must demonstrate significant promise for having a long-term and impactful career in the prostate cancer research field. Awardees must be within six years of completing professional scientific training programs and be under the guidance of at least one mentor.  Eleven of the 2018 PCF Young Investigator Awardees are conducting research to improve prostate cancer outcomes in U.S. Veterans.   Additional research focus areas include: novel precision medicine; new treatments and treatment strategies; immunotherapy; studying inherited genetic alterations for those at increased risk; and prostate cancer disparities particularly among African-American men.  

The 2018 Young Investigator Awards recipients are:

Name

Institution

Donor(s)

- Saud AlDubayan, MD

Harvard: Dana-Farber
Cancer Institute

Paz Littman and Morris Kahn

- Mohammad Asim, PhD

University of Surrey,
United Kingdom

Clovis Oncology, Inc.




- Hala Borno, MD

University of California,
San Francisco

Lenny Sands

- Frank Cackowski, MD, 
  PhD

University of Michigan

Jay Jordan

- Megan Caram, MD

University of Michigan

Tony D. Minella

- Kellie Cotter, PhD

University of Bern,
Switzerland

Todd Boehly

- Anis Hamid, MBBS

Harvard: Dana-Farber
Cancer Institute

Jeremy Coller

- Jennifer Jones, MD, PhD

National Cancer Institute

National Cancer Institute

- Salma Kaochar, PhD

Baylor College of Medicine

John and Daria Barry
Foundation

- Sheng-Yu Ku, PhD

Weill Cornell Medicine

Michael and Lori Milken
Family Foundation

- Hui Li, PhD

University of California,
San Francisco

John and Daria Barry
Foundation

- Brandon Mahal, MD

Harvard: Dana-Farber
Cancer Institute

American Society for
Radiation Oncology

- Danil Makarov, MD

New York University

Thomas H. Lee

- Megan McNamara, MD

Duke University

Thomas Finke

- Kent Mouw, MD, PhD

Harvard: Dana-Farber
Cancer Institute

Rebecca and Nathan
Milikowsky

- Vivek Narayan, MD

University of
Pennsylvania, Abramson
Cancer Center

James Maguire

- David Oh, MD, PhD

University of California,
San Francisco

John and Daria Barry
Foundation

- Eileen Parkes, MD, PhD

Queen's University Belfast,
Northern Ireland

Foundation 14

- Raquel Perez-Lopez, MD,
  PhD

Vall d'Hebron Institute of
Oncology, Spain

Gina Rinehart

- Sethuramasundaram
  Pitchiaya, PhD

University of Michigan

Keith Frankel, Michael
DeAddio, and Thomas H. Lee

- Nicholas Reder, MD,
  MPH

University of Washington

Seth Bernstein

- Zachery Reichert, MD,
  PhD

University of Michigan

Igor Tulchinsky

- Veronica Rodriguez-Bravo, PhD

Thomas Jefferson
University, Sidney Kimmel
Cancer Center

Clay Hamlin in honor of H.
Ward Hamlin Jr.

- Joshua Russo, MD, PhD

Harvard: Beth Israel
Deaconess Medical Center

Michael and Lori Milken
Family Foundation

- Adam Sharp, MD, PhD

Institute of Cancer
Research, London, United Kingdom

Larry Ruvo

- Min Yuen Teo, MD

Memorial Sloan Kettering
Cancer Center

Michael and Lori Milken
Family Foundation in Honor of Selma Rabin

- Vasanthi Viswanathan, PhD

Harvard: Broad Institute of
MIT & Harvard

Seth Bernstein

- Scott Wilkinson, PhD

National Cancer Institute

National Cancer Institute

- David Wise, MD, PhD

New York University

John and Daria Barry Foundation

For more information about the 2018 Young Investigator Awards recipients, visit LINK TO PAGE.

About the Prostate Cancer Foundation (PCF): PCF is the world's leading philanthropic organization funding and accelerating prostate cancer research. Founded in 1993, PCF has raised more than $765 million and provided funding to more than 2,000 research programs at nearly 210 cancer centers and universities. The PCF global research enterprise now extends to 22 countries. PCF advocates for greater awareness of prostate cancer and more efficient investment of governmental research funds for transformational cancer research. Its efforts have helped produce a 20-fold increase in government funding for prostate cancer. For more information, visit www.pcf.org.

MEDIA CONTACT:
Colleen McKenna
Prostate Cancer Foundation
(310) 570-4722
[email protected] 

Donald Wilson
(310) 428-4730
[email protected]

 

Visit pcf.org. (PRNewsFoto/Prostate Cancer Foundation) (PRNewsFoto/Prostate Cancer Foundation)

SOURCE Prostate Cancer Foundation


These press releases may also interest you

at 03:47
Zest Dental Solutions, a global leader in innovative dental solutions proudly announces a strategic partnership with The Pathway. Founded by Justin Moody, DDS and based in Arizona, The Pathway is a continuing education program that teaches dentists...

at 03:34
Medivir AB (STO: MVIR), a pharmaceutical company focused on developing innovative treatments for cancer in areas of high unmet medical need, announced today that its selective cathepsin K inhibitor, MIV-711, has been granted Rare Pediatric Disease...

at 03:16
First quarter Net sales reached SEK 9.4 (13.0) million.The operating result totaled SEK -18.4 (-14.4) million.Earnings per share, basic and diluted, were SEK -0.11 (-0.09).Cash flow from operating activities totaled SEK -7.3 (-12.2) million.CEO...

at 03:03
International medical imaging IT and cybersecurity company Sectra (STO: SECT B) will provide its platform for medical education, Sectra Education Portal, to four university colleges in Denmark. With the solution, they aim to elevate the educational...

at 03:00
Sentrycs, a leading innovator in adaptive counter-drone solutions, is proud to announce its inclusion in the prestigious UK National Protective Security Authority Catalogue of Security Equipment (NPSA CSE).  ...

at 02:22
Swedish Orphan Biovitrum AB (publ) (Sobi®) today announced its report for the first quarter 2024 First Quarter 2024 Total revenue increased 19 per cent, 20 per cent at constant exchange rates, (CER)1, to SEK 6,256 M (5,239)Haematology revenue...



News published on and distributed by: